Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07326878 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Phase I Clinical Trial of Enterovirus Type71 - Coxsackievirus Type A16 Bivalent Vaccine

StatusNot Yet Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 8, 2026 (before its estimated August 15, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
This is a randomized, double-blinded, placebo-controlled phase I clinical trial to evaluate the safety and preliminary immunogenicity of the Enterovirus Type71 - Coxsackievirus Type A16 bivalent vaccine in subjects ( aged 6 months to 59 years ).
Trial Details
NCT Number NCT07326878
Lead Sponsor Institute of Medical Biology, Chinese Academy of Medical Sciences
Collaborators: The Second Affiliated Hospital of Chongqing Medical University
Conditions
(from sponsor)		 Hand, Foot and Mouth Disease (HFMD), HFMD, Hand, Foot and Mouth Disease
Related terms Hand, Foot and Mouth Disease
Enrollment 144 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov